Literature DB >> 25086855

Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - data from a population-based registry.

Joachim Wolf1, Anton Safer2, Johannes C Wöhrle3, Frederick Palm4, Wilfred A Nix5, Matthias Maschke6, Armin J Grau4.   

Abstract

OBJECTIVES: The clinical spectrum of amyotrophic lateral sclerosis (ALS) is characterized by a considerable variation. Different phenotypes have been described by previous studies. We assessed clinical variability and prognostic relevance of these phenotypes in a prospective, population-based cohort of ALS patients in Rhineland-Palatinate, Germany.
METHODS: Incident ALS cases, diagnosed between October 2009 and September 2012, were prospectively enrolled and classified according to established ALS phenotype classification (bulbar, classic, flail arm, flail leg, pyramidal, respiratory). Survival probability was described using Kaplan-Meier method. Moreover, the influence of an additional frontotemporal dementia (FTD) was analysed.
RESULTS: Phenotypes of all 200 patients were determined. Bulbar and classic phenotypes accounted for 75% of all cases. Deterioration of functional impairment during disease progression was lowest in flail leg and pyramidal variants, and most pronounced in bulbar and classic phenotypes. A poor survival prognosis was observed for bulbar, classic or respiratory phenotypes. Patients with an additional FTD showed an even worse outcome.
CONCLUSIONS: Results suggest that ALS is a heterogeneous disease, as ALS phenotypes differ in disease progression and survival time. Patients classified as suffering from bulbar, classic and respiratory ALS, as well as those with an additional FTD, show a marked reduction of survival time.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Frontotemporal dementia; Phenotype; Population register; Prognosis; Survival

Mesh:

Year:  2014        PMID: 25086855     DOI: 10.1016/j.jns.2014.07.033

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

2.  [Causes of death in amyotrophic lateral sclerosis : Results from the Rhineland-Palatinate ALS registry].

Authors:  J Wolf; A Safer; J C Wöhrle; F Palm; W A Nix; M Maschke; A J Grau
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

3.  Epidemiology of amyotrophic lateral sclerosis in Southern Germany.

Authors:  Angela Rosenbohm; Raphael S Peter; Siegfried Erhardt; Dorothée Lulé; Dietrich Rothenbacher; Albert C Ludolph; Gabriele Nagel
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

4.  Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.

Authors:  Christian Lunetta; Andrea Lizio; Eleonora Maestri; Valeria Ada Sansone; Gabriele Mora; Robert G Miller; Stanley H Appel; Adriano Chiò
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

5.  Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging.

Authors:  Feng Tian; Wenlong Yang; Daniel A Mordes; Jin-Yuan Wang; Johnny S Salameh; Joanie Mok; Jeannie Chew; Aarti Sharma; Ester Leno-Duran; Satomi Suzuki-Uematsu; Naoki Suzuki; Steve S Han; Fa-Ke Lu; Minbiao Ji; Rosanna Zhang; Yue Liu; Jack Strominger; Neil A Shneider; Leonard Petrucelli; X Sunney Xie; Kevin Eggan
Journal:  Nat Commun       Date:  2016-10-31       Impact factor: 14.919

Review 6.  What causes amyotrophic lateral sclerosis?

Authors:  Sarah Martin; Ahmad Al Khleifat; Ammar Al-Chalabi
Journal:  F1000Res       Date:  2017-03-28

7.  Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Cinzia Femiano; Francesca Trojsi; Giuseppina Caiazzo; Mattia Siciliano; Carla Passaniti; Antonio Russo; Alvino Bisecco; Mario Cirillo; Maria Rosaria Monsurrò; Fabrizio Esposito; Gioacchino Tedeschi; Gabriella Santangelo
Journal:  Behav Neurol       Date:  2018-10-22       Impact factor: 3.342

Review 8.  Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment.

Authors:  Tereza Filipi; Zuzana Hermanova; Jana Tureckova; Ondrej Vanatko; And Miroslava Anderova
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

9.  Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Kaila L Stipancic; Yana Yunusova; Thomas F Campbell; Jun Wang; James D Berry; Jordan R Green
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

Review 10.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.